Arrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and Management.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 26449143)

Published in J Am Coll Cardiol on October 13, 2015

Authors

Rakesh Gopinathannair1, Susan P Etheridge2, Francis E Marchlinski3, Francis G Spinale4, Dhanunjaya Lakkireddy5, Brian Olshansky6

Author Affiliations

1: Division of Cardiovascular Medicine, University of Louisville, Louisville, Kentucky. Electronic address: rakesh.gopinathannair@louisville.edu.
2: Division of Pediatric Cardiology, University of Utah, Salt Lake City, Utah.
3: Division of Cardiology, University of Pennsylvania, Philadelphia, Pennsylvania.
4: Department of Internal Medicine, University of South Carolina, Charleston, South Carolina.
5: Division of Cardiology, University of Kansas, Kansas City, Kansas.
6: Mercy Heart and Vascular Institute, Mercy Medical Center North Iowa, Mason City, Iowa.

Articles cited by this

(truncated to the top 100)

Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med (2010) 8.17

Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med (2008) 6.17

Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure. Circ Res (2005) 5.34

The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation. J Am Coll Cardiol (2004) 5.05

Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med (2004) 4.99

Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation (2004) 4.04

Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA (2005) 3.89

ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. J Am Coll Cardiol (2003) 3.55

The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med (2003) 3.28

SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation (2004) 3.01

Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol (1997) 2.84

Relationship between burden of premature ventricular complexes and left ventricular function. Heart Rhythm (2010) 2.76

Radiofrequency ablation of frequent, idiopathic premature ventricular complexes: comparison with a control group without intervention. Heart Rhythm (2007) 2.65

Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. Circ Res (1998) 2.16

Electrocardiographic and electrophysiological characteristics of premature ventricular complexes associated with left ventricular dysfunction in patients without structural heart disease. Europace (2012) 2.12

Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol (2003) 2.09

Late enlargement of radiofrequency lesions in infant lambs. Implications for ablation procedures in small children. Circulation (1994) 2.04

Evolving concepts in the management of congenital junctional ectopic tachycardia. A multicenter study. Circulation (1990) 1.92

Reversal of left ventricular dysfunction following ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2006) 1.87

Variable location of accessory pathways associated with the permanent form of junctional reciprocating tachycardia and confirmation with radiofrequency ablation. Am J Cardiol (1992) 1.74

Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia. Circulation (2004) 1.73

Radiofrequency catheter ablation for tachyarrhythmias in children and adolescents. The Pediatric Electrophysiology Society. N Engl J Med (1994) 1.72

Prognostic significance of frequent premature ventricular contractions originating from the ventricular outflow tract in patients with normal left ventricular function. Heart (2009) 1.70

Impact of radiofrequency ablation of frequent post-infarction premature ventricular complexes on left ventricular ejection fraction. Heart Rhythm (2009) 1.67

Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N Engl J Med (2008) 1.65

Pathological role of serum- and glucocorticoid-regulated kinase 1 in adverse ventricular remodeling. Circulation (2012) 1.65

The cellular basis of pacing-induced dilated cardiomyopathy. Myocyte cell loss and myocyte cellular reactive hypertrophy. Circulation (1995) 1.56

Novel SCN5A mutation in amiodarone-responsive multifocal ventricular ectopy-associated cardiomyopathy. Heart Rhythm (2014) 1.55

Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function. Circ Res (1998) 1.49

Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems. Circulation (1997) 1.42

Idiopathic ventricular tachycardia in infancy and childhood: a multicenter study on clinical profile and outcome. Working Group on Dysrhythmias and Electrophysiology of the Association for European Pediatric Cardiology. J Am Coll Cardiol (1999) 1.41

Rapid ventricular pacing in the dog: pathophysiologic studies of heart failure. Circulation (1986) 1.38

Tachycardiomyopathy: mechanisms and clinical implications. Pacing Clin Electrophysiol (1996) 1.36

Atrial fibrillation and ventricular dysfunction: a vicious electromechanical cycle. Circulation (2004) 1.34

Amiodarone therapy for drug-refractory fetal tachycardia. Circulation (2004) 1.29

Characteristics of premature ventricular complexes as correlates of reduced left ventricular systolic function: study of the burden, duration, coupling interval, morphology and site of origin of PVCs. J Cardiovasc Electrophysiol (2011) 1.22

Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens. J Am Coll Cardiol (1999) 1.21

Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective. Cardiovasc Res (2002) 1.21

Changes in left ventricular volume, mass, and function during the development and regression of supraventricular tachycardia-induced cardiomyopathy. Disparity between recovery of systolic versus diastolic function. Circulation (1991) 1.18

Impact of QRS duration of frequent premature ventricular complexes on the development of cardiomyopathy. Heart Rhythm (2012) 1.18

Left ventricular systolic dysfunction induced by ventricular ectopy: a novel model for premature ventricular contraction-induced cardiomyopathy. Circ Arrhythm Electrophysiol (2011) 1.17

Radiofrequency ablation of premature ventricular ectopy improves the efficacy of cardiac resynchronization therapy in nonresponders. J Am Coll Cardiol (2012) 1.16

Clinical course of atrial ectopic tachycardia is age-dependent: results and treatment in children < 3 or > or =3 years of age. J Am Coll Cardiol (2004) 1.16

Recovery from left ventricular dysfunction after ablation of frequent premature ventricular complexes. Heart Rhythm (2012) 1.13

Long-term outcomes after catheter ablation of cavo-tricuspid isthmus dependent atrial flutter: a meta-analysis. Circ Arrhythm Electrophysiol (2009) 1.11

Collagen remodeling and changes in LV function during development and recovery from supraventricular tachycardia. Am J Physiol (1991) 1.09

Auricular fibrillation without other evidence of heart disease; a cause of reversible heart failure. Am J Med (1949) 1.09

Tachycardia-mediated cardiomyopathy secondary to focal atrial tachycardia: long-term outcome after catheter ablation. J Am Coll Cardiol (2009) 1.07

Diagnostic approach and treatment strategy in tachycardia-induced cardiomyopathy. Clin Cardiol (2008) 1.07

Reversal of dilated cardiomyopathy by the elimination of frequent left or right premature ventricular contractions. J Interv Card Electrophysiol (2007) 1.06

Chronic supraventricular tachycardia causes ventricular dysfunction and subendocardial injury in swine. Am J Physiol (1990) 1.06

Clinical approach to genetic cardiomyopathy in children. Circulation (1996) 1.05

Reversible symptomatic dilated cardiomyopathy in older children and young adolescents due to primary non-sinus supraventricular tachyarrhythmias. Pediatr Cardiol (2003) 1.05

Alterations in left ventricular torsion in tachycardia-induced dilated cardiomyopathy. J Thorac Cardiovasc Surg (2002) 1.05

Abnormalities in intracellular calcium regulation and contractile function in myocardium from dogs with pacing-induced heart failure. J Clin Invest (1992) 1.04

Ventricular premature depolarization QRS duration as a new marker of risk for the development of ventricular premature depolarization-induced cardiomyopathy. Heart Rhythm (2013) 1.03

Tachycardia and cardiomyopathy: the chicken-egg dilemma revisited. J Am Coll Cardiol (1985) 1.02

Mechanisms of cardiac arrhythmias. Rev Esp Cardiol (Engl Ed) (2011) 1.02

Myocyte nuclear mitotic division and programmed myocyte cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs. Lab Invest (1995) 1.02

Cardiac arrhythmias in the human fetus. Pediatr Cardiol (2004) 1.02

Junctional ectopic tachycardia in children: electrocardiography, electrophysiology and pharmacologic response. Am J Cardiol (1979) 1.02

A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study). Heart (2009) 1.00

Pediatric nonpost-operative junctional ectopic tachycardia medical management and interventional therapies. J Am Coll Cardiol (2009) 0.99

Effect of heart failure on the mechanism of exercise-induced augmentation of mitral valve flow. Circ Res (1993) 0.98

Frequent premature ventricular complexes originating from the right ventricular outflow tract are associated with left ventricular dysfunction. Ann Noninvasive Electrocardiol (2008) 0.98

Neurohormonal, structural, and functional recovery pattern after premature ventricular complex ablation is independent of structural heart disease status in patients with depressed left ventricular ejection fraction: a prospective multicenter study. J Am Coll Cardiol (2013) 0.98

Predictors of myocardial recovery in pediatric tachycardia-induced cardiomyopathy. Heart Rhythm (2014) 0.97

Early recovery from heart failure: insights into the pathogenesis of experimental chronic pacing-induced heart failure. J Lab Clin Med (1988) 0.96

Alterations in myocyte shape and basement membrane attachment with tachycardia-induced heart failure. Circ Res (1991) 0.96

Clinical characteristics, treatment, and outcome of tachycardia induced cardiomyopathy. Int Heart J (2008) 0.96

Tachycardia-mediated cardiomyopathy: recognition and management. Curr Heart Fail Rep (2009) 0.95

Relation of symptoms and symptom duration to premature ventricular complex-induced cardiomyopathy. Heart Rhythm (2011) 0.95

LV and myocyte structure and function after early recovery from tachycardia-induced cardiomyopathy. Am J Physiol (1995) 0.95

Incessant ventricular tachycardia in infants: myocardial hamartomas and surgical cure. J Am Coll Cardiol (1987) 0.94

Selective catheter ablation of the tachycardia focus in patients with nonreentrant junctional tachycardia. Am J Cardiol (1996) 0.94

Cellular and extracellular remodeling with the development and recovery from tachycardia-induced cardiomyopathy: changes in fibrillar collagen, myocyte adhesion capacity and proteoglycans. J Mol Cell Cardiol (1996) 0.93

Reversal of outflow tract ventricular premature depolarization-induced cardiomyopathy with ablation: effect of residual arrhythmia burden and preexisting cardiomyopathy on outcome. Heart Rhythm (2011) 0.93

Exhaustion of Frank-Starling mechanism in conscious dogs with heart failure. Am J Physiol (1993) 0.93

The role of interpolation in PVC-induced cardiomyopathy. Heart Rhythm (2011) 0.92

Reduced NO-dependent arteriolar dilation during the development of cardiomyopathy. Am J Physiol Heart Circ Physiol (2000) 0.91

Congenital junctional ectopic tachycardia in children and adolescents: a 20 year experience based study. Heart (2002) 0.90

Tachycardia induced cardiomyopathy in dogs; relation between chronic supraventricular and chronic ventricular tachycardia. Int J Cardiol (1996) 0.90

Alterations in myocardial contractility in conscious dogs with dilated cardiomyopathy. Am J Physiol (1991) 0.89

Clinical spectrum, therapeutic management, and follow-up of ventricular tachycardia in infants and young children. Am Heart J (1996) 0.89

Relative efficacy of catheter ablation vs antiarrhythmic drugs in treating premature ventricular contractions: a single-center retrospective study. Heart Rhythm (2013) 0.88

Tachycardia-induced cardiomyopathy: mechanisms of heart failure and clinical implications. J Cardiovasc Med (Hagerstown) (2007) 0.88

Premature atrial contraction-induced cardiomyopathy. Europace (2013) 0.88

Long-term follow-up after atrial fibrillation ablation in patients with impaired left ventricular systolic function: the importance of rhythm and rate control. Heart Rhythm (2013) 0.88

Evaluation of indices of left ventricular contractility and relaxation in evolving canine experimental heart failure. Cardiovasc Res (1992) 0.88

Heart failure and atrial fibrillation: from basic science to clinical practice. Int J Mol Sci (2015) 0.87

Permanent junctional reciprocating tachycardia in children: a multicentre study on clinical profile and outcome. Heart (2005) 0.87

Transcatheter cryothermal ablation of junctional ectopic tachycardia in the normal heart. Heart Rhythm (2006) 0.87

Diffuse ventricular fibrosis is a late outcome of tachycardia-mediated cardiomyopathy after successful ablation. Circ Arrhythm Electrophysiol (2013) 0.86

Persistent left ventricular dilatation in tachycardia-induced cardiomyopathy patients after appropriate treatment and normalization of ejection fraction. Heart Rhythm (2008) 0.86

Late gadolinium enhancement CMR in patients with tachycardia-induced cardiomyopathy caused by idiopathic ventricular arrhythmias. Pacing Clin Electrophysiol (2012) 0.85

Atrial natriuretic peptide in congestive heart failure in the dog: plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects. Circulation (1988) 0.85

Compensatory downregulation of myocardial Ca channel in SR from dogs with heart failure. Am J Physiol (1993) 0.85

Diagnostic accuracy of NT-proBNP ratio (BNP-R) for early diagnosis of tachycardia-mediated cardiomyopathy: a pilot study. Clin Res Cardiol (2011) 0.85

New unipolar electrogram criteria to identify irreversibility of nonischemic left ventricular cardiomyopathy. J Am Coll Cardiol (2012) 0.84

A novel RyR2 mutation in a 2-year-old baby presenting with atrial fibrillation, atrial flutter, and atrial ectopic tachycardia. Heart Rhythm (2014) 0.84